GBA mutations are a major risk factor for PD and DLB [1, 42, 48], so the impairment of GCase activity in FTD-GRN patients and Grn−/− mice raises the question of whether GRN mutations or variants may also increase PD and DLB risk. The gene discussed is GBA1; the disease is Parkinson disease.